H1’s Post

Diversity in clinical trials goes beyond regulatory requirements—it’s a cornerstone of ethical research and scientific integrity. Ryan Brown, H1’s Regional VP of Sales, shares about the critical need for diverse populations in clinical studies in this Xtalks Spotlight with Vera Kovacevic. She explores how clinical research teams can use data-driven approaches to foster diversity in research. Watch now: https://hubs.la/Q02_7P5_0 #clinicaltrialdiversity #healthequity #patientdiversity #equitableresearch

We spoke to Stacy Weil, Senior Vice President at Premier Research about the importance of integrating #DEI in clinical research as both a social and scientific imperative. Read more about why early planning is critical to the development of DEI strategies here: https://buff.ly/3XgecHT #DiversityEquityInclusion #DEIinClinicalResearch #ClinialResearch #ClinicalTrials

Check out Xtalks' new article in collaboration with Stacy Weil, where they discuss the importance of incorporating #DEI strategies into clinical research and why early planning is imperative. https://lnkd.in/e6cn-5Ss #Diversity #Equity #Inclusion #ClinicalResearch

The clinical research industry is increasingly aware of the importance of diversity and representation in clinical trials, but improving the situation is proving challenging. This article outlines the role of trust in engaging underrepresented groups in clinical trials, and how technology can help. https://buff.ly/3yVj3pR #representation #clinicalreserch #diversity #clinicaltrials

To foster diversity and inclusion in the clinical research industry, building trust is absolutely critical. And making treatments effective and safe for all patients regardless of race, ethnicity, socioeconomic status, and other factors requires a multifaceted approach across the entire industry. In his latest piece for Forbes Technology Council, our CEO Gadi Saarony shares insights into why fear and mistrust of clinical trials still exists in many communities today, despite research being highly regulated, and how we can leverage technology to increase trust. Read it here: https://lnkd.in/epdza8kP #ClinicalResearch #ClinicalTrials #DEI

Metrics are vital signposts on the road of clinical research for precision and objectivity. Learn more about the value of metrics and their impact on the success of clinical research. https://lnkd.in/eChPKkqf #clinicalresearch #metrics

When we say someone is "underserved" by clinical research, what do we mean? Clinical Excellence GmbH's Jessica Cordes defines "underserved," gives some examples, discusses the barriers to the groups' participation, and offers strategies for their inclusion — all based on the NIHR (National Institute for Health and Care Research) Clinical Research Network (NIHR CRN) INCLUDE Project. #clinicaltrials #clinicalresearch

High-quality data is the lifeblood of clinical research. Learn more about the value of metrics and their impact on the success of clinical research. https://lnkd.in/eChPKkqf #clinicalresearch #clinicaldata

Joining a research study or clinical trial can involve a lot of alphabet soup for the patient given all the complexity involved.  As noted in a recent #ACRP blog post, a new initiative from The Multi-Regional Clinical Trials Center is aiming to provide a glossary of common clinical research terms for use by research professionals and patients alike: https://lnkd.in/duSeQd_8   At Chartis, we strive to work with research leaders to keep patients at the center of their care, including best practices on participant-facing communication and study design.  We’re here to strategize on best practices and how to implement in your organization.    #ClinicalTrials #HealthLiteracy #ClinicalResearch  

Navigating the clinical and translational research world? Chartis can help you with the ABC's.